Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
The most suitble way to Exchange Bitcoin (BTC) to PayPal
-
Inflation Anxiety, XRP Fake News Keep Crypto Market Muted
-
Analyst Predicts 90% Likelihood of SEC Approving Bitcoin Spot ETF by January 2024 or Earlier
-
Still Bullish: Billionaire Money Manager Bill Miller Maintains View Bitcoin Will Rise Again Despite FTX Chaos
-
Cryptos Muted Ahead Of Key Economic Data Updates